bibliographic resource 1181206 [br/1181206]
https://w3id.org/oc/corpus/br/1181206

is a
title
  • Phase III Randomized, Placebo-Controlled Study of Cetuximab Plus Brivanib Alaninate Versus Cetuximab Plus Placebo in Patients With Metastatic, Chemotherapy-Refractory, Wild-Type K-RAS Colorectal Carcinoma: The NCIC Clinical Trials Group and AGITG CO.20 Trial
publication date
  • 2013-01-01
contributor
format
identifier
part of